Artículos de revistas sobre el tema "C3 complement deposition"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "C3 complement deposition".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
RAINARD, PASCAL. "Complement factor B and the alternative pathway of complement activation in bovine milk". Journal of Dairy Research 69, n.º 1 (febrero de 2002): 1–12. http://dx.doi.org/10.1017/s0022029901005337.
Texto completoWang, Fengying, Xiaozhong Li, Xueming Zhu, Qing Chen, Lu Jiang y Ziqiang Zhu. "Renal Tubular Complement 3 Deposition in Children with Primary Nephrotic Syndrome". BioMed Research International 2018 (30 de mayo de 2018): 1–9. http://dx.doi.org/10.1155/2018/4386438.
Texto completoZhang, Mason X., Tristan T. Brandhorst, Thomas R. Kozel y Bruce S. Klein. "Role of Glucan and Surface Protein BAD1 in Complement Activation by Blastomyces dermatitidisYeast". Infection and Immunity 69, n.º 12 (1 de diciembre de 2001): 7559–64. http://dx.doi.org/10.1128/iai.69.12.7559-7564.2001.
Texto completoRen, Bing, Alexander J. Szalai, Susan K. Hollingshead y David E. Briles. "Effects of PspA and Antibodies to PspA on Activation and Deposition of Complement on the Pneumococcal Surface". Infection and Immunity 72, n.º 1 (enero de 2004): 114–22. http://dx.doi.org/10.1128/iai.72.1.114-122.2004.
Texto completoPark, Seohyun, Hyung Woo Kim, Jung Tak Park, Tae Ik Chang, Ea Wha Kang, Dong-Ryeol Ryu, Tae-Hyun Yoo et al. "Relationship between complement deposition and the Oxford classification score and their combined effects on renal outcome in immunoglobulin A nephropathy". Nephrology Dialysis Transplantation 35, n.º 12 (3 de agosto de 2019): 2103–37. http://dx.doi.org/10.1093/ndt/gfz161.
Texto completoStåhl, Anne-lie, Fariba Vaziri-Sani, Stefan Heinen, Ann-Charlotte Kristoffersson, Karl-Henrik Gydell, Reem Raafat, Alberto Gutierrez, Ortraud Beringer, Peter F. Zipfel y Diana Karpman. "Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation". Blood 111, n.º 11 (1 de junio de 2008): 5307–15. http://dx.doi.org/10.1182/blood-2007-08-106153.
Texto completoBlok, Vanessa T., Mohamed R. Daha, Odette Tijsma, Claire L. Harris, B. Paul Morgan, Gert Jan Fleuren y Arko Gorter. "A Bispecific Monoclonal Antibody Directed Against Both the Membrane-Bound Complement Regulator CD55 and the Renal Tumor-Associated Antigen G250 Enhances C3 Deposition and Tumor Cell Lysis by Complement". Journal of Immunology 160, n.º 7 (1 de abril de 1998): 3437–43. http://dx.doi.org/10.4049/jimmunol.160.7.3437.
Texto completoGates, Marcellene A. y Thomas R. Kozel. "Differential Localization of Complement Component 3 within the Capsular Matrix of Cryptococcus neoformans". Infection and Immunity 74, n.º 6 (junio de 2006): 3096–106. http://dx.doi.org/10.1128/iai.01213-05.
Texto completoWozencraft, A. O., G. Sayers y J. M. Blackwell. "Macrophage type 3 complement receptors mediate serum-independent binding of Leishmania donovani. Detection of macrophage-derived complement on the parasite surface by immunoelectron microscopy." Journal of Experimental Medicine 164, n.º 4 (1 de octubre de 1986): 1332–37. http://dx.doi.org/10.1084/jem.164.4.1332.
Texto completoCook, H. Terence. "C3 glomerulopathy". F1000Research 6 (10 de marzo de 2017): 248. http://dx.doi.org/10.12688/f1000research.10364.1.
Texto completoHindmarsh, Elizabeth J. y Rory M. Marks. "Complement Activation Occurs on Subendothelial Extracellular Matrix In Vitro and Is Initiated by Retraction or Removal of Overlying Endothelial Cells". Journal of Immunology 160, n.º 12 (15 de junio de 1998): 6128–36. http://dx.doi.org/10.4049/jimmunol.160.12.6128.
Texto completoHeeringa, Saskia F. y Clemens D. Cohen. "Kidney Diseases Caused by Complement Dysregulation: Acquired, Inherited, and Still More to Come". Clinical and Developmental Immunology 2012 (2012): 1–6. http://dx.doi.org/10.1155/2012/695131.
Texto completoSkuk, Daniel y Jacques P. Tremblay. "Complement Deposition and Cell Death after Myoblast Transplantation". Cell Transplantation 7, n.º 5 (septiembre de 1998): 427–34. http://dx.doi.org/10.1177/096368979800700501.
Texto completoSabharwal, Vishakha, Sanjay Ram, Marisol Figueira, In Ho Park y Stephen I. Pelton. "Role of Complement in Host Defense against Pneumococcal Otitis Media". Infection and Immunity 77, n.º 3 (12 de enero de 2009): 1121–27. http://dx.doi.org/10.1128/iai.01148-08.
Texto completoTaylor, Ronald P., Andrew W. Pawluczkowycz, Margaret A. Lindorfer y John W. Waitumbi. "Hematin Promotes Complement Alternative Pathway-Mediated Deposition of C3 Activation Fragments on Human Erythrocytes: Potential Implications for the Pathogenesis of Anemia in Malaria." Blood 110, n.º 11 (16 de noviembre de 2007): 839. http://dx.doi.org/10.1182/blood.v110.11.839.839.
Texto completoBjornson, A. B., P. I. Magnafichi, R. D. Schreiber y H. S. Bjornson. "Opsonization of bacteroides by the alternative complement pathway reconstructed from isolated plasma proteins." Journal of Experimental Medicine 165, n.º 3 (1 de marzo de 1987): 777–98. http://dx.doi.org/10.1084/jem.165.3.777.
Texto completoStänder, Sascha, Maike M. Holtsche, Enno Schmidt, Christoph M. Hammers, Detlef Zillikens, Ralf J. Ludwig y Khalaf Kridin. "Presence of Cutaneous Complement Deposition Distinguishes between Immunological and Histological Features of Bullous Pemphigoid—Insights from a Retrospective Cohort Study". Journal of Clinical Medicine 9, n.º 12 (3 de diciembre de 2020): 3928. http://dx.doi.org/10.3390/jcm9123928.
Texto completoOhishi, K., M. Kanoh, H. Shinomiya, Y. Hitsumoto y S. Utsumi. "Complement activation by cross-linked B cell-membrane IgM." Journal of Immunology 154, n.º 7 (1 de abril de 1995): 3173–79. http://dx.doi.org/10.4049/jimmunol.154.7.3173.
Texto completoMalik, Talat H., Daniel P. Gitterman, Deborah P. Lavin, Hannah J. Lomax-Browne, E. Christina Hiemeyer, Linda B. Moran, Katharina Boroviak et al. "Gain-of-function factor H–related 5 protein impairs glomerular complement regulation resulting in kidney damage". Proceedings of the National Academy of Sciences 118, n.º 13 (22 de marzo de 2021): e2022722118. http://dx.doi.org/10.1073/pnas.2022722118.
Texto completoRosas, Á L., R. S. MacGill, J. D. Nosanchuk, T. R. Kozel y A. Casadevall. "Activation of the Alternative Complement Pathway by Fungal Melanins". Clinical and Vaccine Immunology 9, n.º 1 (enero de 2002): 144–48. http://dx.doi.org/10.1128/cdli.9.1.144-148.2002.
Texto completoTofferi, J., S. Peng y C. M. Moratz. "C3b-Independent Complement Activation in Ischemia/Reperfusion Mesenteric Tissue Injury in Autoimmune Prone (B6.MRL/lpr) Mice". ISRN Immunology 2012 (16 de septiembre de 2012): 1–9. http://dx.doi.org/10.5402/2012/702858.
Texto completoMener, Amanda, Connie M. Arthur, Seema R. Patel y Sean R. Stowell. "C3 Modulates RBC Antigen to Negatively Regulate Antibody Response". Blood 128, n.º 22 (2 de diciembre de 2016): 22. http://dx.doi.org/10.1182/blood.v128.22.22.22.
Texto completoMelin, Merit, Krzysztof Trzciński, Seppo Meri, Helena Käyhty y Merja Väkeväinen. "The Capsular Serotype of Streptococcus pneumoniae Is More Important than the Genetic Background for Resistance to Complement". Infection and Immunity 78, n.º 12 (20 de septiembre de 2010): 5262–70. http://dx.doi.org/10.1128/iai.00740-10.
Texto completoDomínguez, Mercedes, Inmaculada Moreno, Margarita López-Trascasa y Alfredo Toraño. "Complement Interaction with Trypanosomatid Promastigotes in Normal Human Serum". Journal of Experimental Medicine 195, n.º 4 (18 de febrero de 2002): 451–59. http://dx.doi.org/10.1084/jem.20011319.
Texto completoGiacomin, Paul R., Hui Wang, David L. Gordon, Marina Botto y Lindsay A. Dent. "Loss of Complement Activation and Leukocyte Adherence as Nippostrongylus brasiliensis Develops within the Murine Host". Infection and Immunity 73, n.º 11 (noviembre de 2005): 7442–49. http://dx.doi.org/10.1128/iai.73.11.7442-7449.2005.
Texto completoChaikof, Elliot L., Edward W. Merrill, Allan D. Callow, Raymond J. Connolly, Sylvie L. Verdon y Karen Ramberg. "PEO enhancement of platelet deposition, fibrinogen deposition, and complement C3 activation". Journal of Biomedical Materials Research 26, n.º 9 (septiembre de 1992): 1163–68. http://dx.doi.org/10.1002/jbm.820260906.
Texto completoRoumenina, Lubka T., Mathieu Jablonski, Christophe Hue, Jacques Blouin, Jordan D. Dimitrov, Marie-Agnes Dragon-Durey, Mathieu Cayla et al. "Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome". Blood 114, n.º 13 (24 de septiembre de 2009): 2837–45. http://dx.doi.org/10.1182/blood-2009-01-197640.
Texto completoLi, Jie, David T. Glover, Alexander J. Szalai, Susan K. Hollingshead y David E. Briles. "PspA and PspC Minimize Immune Adherence and Transfer of Pneumococci from Erythrocytes to Macrophages through Their Effects on Complement Activation". Infection and Immunity 75, n.º 12 (8 de octubre de 2007): 5877–85. http://dx.doi.org/10.1128/iai.00839-07.
Texto completoHarboe, Morten, Christina Johnson, Stig Nymo, Karin Ekholt, Camilla Schjalm, Julie K. Lindstad, Anne Pharo et al. "Properdin binding to complement activating surfaces depends on initial C3b deposition". Proceedings of the National Academy of Sciences 114, n.º 4 (9 de enero de 2017): E534—E539. http://dx.doi.org/10.1073/pnas.1612385114.
Texto completoPanicker, Sandip, Ju Shi, Eileen Rose, Sami Hussain, Susan Tom, William Strober, Steven R. Sloan, Graham Parry y Nancy Stagliano. "TNT009, a Classical Complement Pathway Specific Inhibitor, Prevents Complement Dependent Hemolysis Induced By Cold Agglutinin Disease Patient Autoantibodies". Blood 122, n.º 21 (15 de noviembre de 2013): 42. http://dx.doi.org/10.1182/blood.v122.21.42.42.
Texto completoRisitano, Antonio M., Patrizia Ricci, Caterina Pascariello, Maddalena Raia, Christoph Q. Schmidt, Yingxue Li, Edimara S. Reis et al. "Novel Complement Modulators for Paroxysmal Nocturnal Hemoglobinuria: Peptide and Protein Inhibitors of C3 Convertase Prevent Both Surface C3 Deposition and Subsequent Hemolysis of Affected Erythrocytes in Vitro". Blood 120, n.º 21 (16 de noviembre de 2012): 370. http://dx.doi.org/10.1182/blood.v120.21.370.370.
Texto completoSimovic, Milomir O., Michael J. Falabella, Tuan D. Le, Jurandir J. DalleLucca y Yansong Li. "Decay-Accelerating Factor Creates an Organ-Protective Phenotype after Hemorrhage in Conscious Rats". International Journal of Molecular Sciences 23, n.º 21 (5 de noviembre de 2022): 13563. http://dx.doi.org/10.3390/ijms232113563.
Texto completoLapidot, Rotem, Mario Ramirez, Dayeun Lee, Ingrid L. Scully, Bradford D. Gessner y stephen pelton. "1000. Serotype 3 pneumococci evade activation of the classical complement pathway". Open Forum Infectious Diseases 8, Supplement_1 (1 de noviembre de 2021): S591. http://dx.doi.org/10.1093/ofid/ofab466.1194.
Texto completoMatsumoto, M., F. Yamashita, K. Iida, M. Tomita y T. Seya. "Purification and characterization of a human membrane protein that activates the alternative complement pathway and allows the deposition of homologous complement C3." Journal of Experimental Medicine 181, n.º 1 (1 de enero de 1995): 115–25. http://dx.doi.org/10.1084/jem.181.1.115.
Texto completoSanti, P., K. A. Joiner, C. H. Hammer, M. M. Frank y R. Tosi. "A complement-resistant HeLa cell line (T638) is blocked at the step of C3 deposition." Journal of Immunology 138, n.º 10 (15 de mayo de 1987): 3385–91. http://dx.doi.org/10.4049/jimmunol.138.10.3385.
Texto completoPedersen, Henrik, Rasmus K. Jensen, Annette G. Hansen, Trine A. F. Gadeberg, Steffen Thiel, Nick S. Laursen y Gregers R. Andersen. "A C3-specific nanobody that blocks all three activation pathways in the human and murine complement system". Journal of Biological Chemistry 295, n.º 26 (6 de mayo de 2020): 8746–58. http://dx.doi.org/10.1074/jbc.ra119.012339.
Texto completoMichelfelder, Stefan, Friedericke Fischer, Astrid Wäldin, Kim V. Hörle, Martin Pohl, Juliana Parsons, Ralf Reski et al. "The MFHR1 Fusion Protein Is a Novel Synthetic Multitarget Complement Inhibitor with Therapeutic Potential". Journal of the American Society of Nephrology 29, n.º 4 (15 de enero de 2018): 1141–53. http://dx.doi.org/10.1681/asn.2017070738.
Texto completoFuhrman, S. A. y K. A. Joiner. "Toxoplasma gondii: mechanism of resistance to complement-mediated killing." Journal of Immunology 142, n.º 3 (1 de febrero de 1989): 940–47. http://dx.doi.org/10.4049/jimmunol.142.3.940.
Texto completoOng, Gaik Lin, Purvin B. Shah y M. Jules Mattes. "Rabbit Complement Lyses Tumor Cells Without Massive C3 Deposition". Immunological Investigations 25, n.º 3 (enero de 1996): 215–29. http://dx.doi.org/10.3109/08820139609059304.
Texto completoSchwendinger, M. G., M. Spruth, J. Schoch, M. P. Dierich y W. M. Prodinger. "A novel mechanism of alternative pathway complement activation accounts for the deposition of C3 fragments on CR2-expressing homologous cells." Journal of Immunology 158, n.º 11 (1 de junio de 1997): 5455–63. http://dx.doi.org/10.4049/jimmunol.158.11.5455.
Texto completoPuentes, S. M., D. L. Sacks, R. P. da Silva y K. A. Joiner. "Complement binding by two developmental stages of Leishmania major promastigotes varying in expression of a surface lipophosphoglycan." Journal of Experimental Medicine 167, n.º 3 (1 de marzo de 1988): 887–902. http://dx.doi.org/10.1084/jem.167.3.887.
Texto completoMelin, Merit, Krzysztof Trzciński, Martin Antonio, Seppo Meri, Richard Adegbola, Tarja Kaijalainen, Helena Käyhty y Merja Väkeväinen. "Serotype-Related Variation in Susceptibility to Complement Deposition and Opsonophagocytosis among Clinical Isolates of Streptococcus pneumoniae". Infection and Immunity 78, n.º 12 (20 de septiembre de 2010): 5252–61. http://dx.doi.org/10.1128/iai.00739-10.
Texto completoYadav, Sudhir K., Naoko Ito, Devika Soin, Kouichi Ito y Suhayl Dhib-Jalbut. "Dimethyl Fumarate Suppresses Demyelination and Axonal Loss through Reduction in Pro-Inflammatory Macrophage-Induced Reactive Astrocytes and Complement C3 Deposition". Journal of Clinical Medicine 10, n.º 4 (19 de febrero de 2021): 857. http://dx.doi.org/10.3390/jcm10040857.
Texto completoKuo, Chih-Feng, Yee-Shin Lin, Woei-Jer Chuang, Jiunn-Jong Wu y Nina Tsao. "Degradation of Complement 3 by Streptococcal Pyrogenic Exotoxin B Inhibits Complement Activation and Neutrophil Opsonophagocytosis". Infection and Immunity 76, n.º 3 (3 de enero de 2008): 1163–69. http://dx.doi.org/10.1128/iai.01116-07.
Texto completoKnežević, T., I. Padjen, V. Ivković, S. Bulimbašić, M. Ćorić, I. Jezic, Z. Biloglav, M. Laganović y B. Anic. "AB0575 MESANGIAL C1Q DEPOSITION, BUT NOT C3 AND C1Q DEPOSITION IN OTHER RENAL COMPARTMENTS, IS A PREDICTOR OF RENAL OUTCOME IN LUPUS NEPHRITIS". Annals of the Rheumatic Diseases 81, Suppl 1 (23 de mayo de 2022): 1413.2–1413. http://dx.doi.org/10.1136/annrheumdis-2022-eular.5363.
Texto completoShi, Tong, Vaishali R. Moulton, Peter H. Lapchak, Guo-Min Deng, Jurandir J. Dalle Lucca y George C. Tsokos. "Ischemia-mediated aggregation of the actin cytoskeleton is one of the major initial events resulting in ischemia-reperfusion injury". American Journal of Physiology-Gastrointestinal and Liver Physiology 296, n.º 2 (febrero de 2009): G339—G347. http://dx.doi.org/10.1152/ajpgi.90607.2008.
Texto completoRieben, Robert, Anja Roos, Yvonne Muizert, Caroline Tinguely, Arnout F. Gerritsen y Mohamed R. Daha. "Immunoglobulin M–Enriched Human Intravenous Immunoglobulin Prevents Complement Activation In Vitro and In Vivo in a Rat Model of Acute Inflammation". Blood 93, n.º 3 (1 de febrero de 1999): 942–51. http://dx.doi.org/10.1182/blood.v93.3.942.
Texto completoRieben, Robert, Anja Roos, Yvonne Muizert, Caroline Tinguely, Arnout F. Gerritsen y Mohamed R. Daha. "Immunoglobulin M–Enriched Human Intravenous Immunoglobulin Prevents Complement Activation In Vitro and In Vivo in a Rat Model of Acute Inflammation". Blood 93, n.º 3 (1 de febrero de 1999): 942–51. http://dx.doi.org/10.1182/blood.v93.3.942.403k31_942_951.
Texto completoLee, Jong-Ho, Na-Hyang Kim, Volker Winstel, Kenji Kurokawa, Jesper Larsen, Jang-Hyun An, Adnan Khan et al. "Surface Glycopolymers Are Crucial forIn VitroAnti-Wall Teichoic Acid IgG-Mediated Complement Activation and Opsonophagocytosis of Staphylococcus aureus". Infection and Immunity 83, n.º 11 (17 de agosto de 2015): 4247–55. http://dx.doi.org/10.1128/iai.00767-15.
Texto completoMarquart, H. V., S. E. Svehag y R. G. Leslie. "CR2 is the primary acceptor site for C3 during alternative pathway activation of complement on human peripheral B lymphocytes." Journal of Immunology 153, n.º 1 (1 de julio de 1994): 307–15. http://dx.doi.org/10.4049/jimmunol.153.1.307.
Texto completo